ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Study Protocol

The effect of manual therapy on diaphragm function in adults with asthma: Protocol for a randomized controlled trial

[version 1; peer review: 2 approved with reservations]
PUBLISHED 18 Oct 2023
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the HEAL1000 gateway.

Abstract

Background: Diaphragm dysfunction is prevalent among individuals with asthma due to lung hyperinflation and hyperventilation in asthma paroxysm. This study was designed to evaluate the effect of the manual diaphragm release technique (MDRT) on diaphragm function in individuals with asthma.

Methods: Adults with diagnosed stable asthma (n = 24), will be recruited from the General Hospital of Kifissia “Agioi Anargyroi” in Athens, Greece. The volunteers who meet the inclusion criteria will be randomly allocated to two groups: (a) the experimental group (n = 12) that will receive 12 sessions of MDRT in conjunction with breathing retraining exercises (BRE), and (b) the control group (n = 12) that will receive 12 sessions of BRE. Measurements will occur at three time points: before the initiation of treatment sessions (week 0), followed by 12 treatment sessions (week 6), and three months from the beginning of the trial (week 12). The main outcomes will be the diaphragm excursion (ultrasonography) and chest expansion (inch tape), with secondary outcomes the maximal respiratory pressures (digital pressure manometer), dysfunctional breathing (Nijmegen questionnaire), asthma control (ACT), dyspnea (Borg scale) and quality of life (SF-12v2).

Discussion: The proposed protocol is the first to examine the effectiveness of MRDT on diaphragm’s function in individuals with asthma. Manual Therapy (MT) is a low-cost alternative and supplementary therapy to standard treatment procedures that might improve the biomechanics of respiration in pulmonary rehabilitation.

Trial Registration: Registered on Clinical Trials.gov (ID: NCT05709054)

Protocol version: 29/09/2023

Keywords

Key Words: Asthma; Manual Therapy; Diaphragm; Breathing retraining exercises; Diaphragm mobility, Ultrasound

Introduction

Due to its anatomical structure and contribution to minute ventilation (60–80%), the diaphragm is the most important respiratory muscle. 1 3 An impaired diaphragm is associated with respiratory symptoms such as dyspnea, intolerance to exercise and sleep problems. 4

Chronic obstructive pulmonary disease (COPD) and asthma are umbrella terms for various conditions characterized by chronic airway disease. 5 COPD and asthma patients frequently experience diaphragmatic dysfunction (DD). 6 The diaphragm’s ability to raise and expand the lower ribcage within the zone of apposition (ZOA), where the lower ribcage directly interacts with the diaphragm becomes compromised due to mechanical challenges. This is due to the diaphragm functioning at a disadvantageous shortened position caused by air trapping, which hinders its contraction capacity and increases the respiratory workload. 7

In COPD, air progressively remains trapped in the lungs due to airway constriction. The architecture of the thoracic cage is disrupted by this clinical condition during exercise and rest, reducing the diaphragm’s physiological advantage. 8 , 9 Similarly, Individuals with moderate to severe asthma may have pulmonary overstretching (asthma paroxysm), which can cause functional problems because it reduces expiratory flow (early airway closure), activates inspiratory muscles at the end of expiration, and reduces lung flexibility. 10 12 Although the underlying mechanisms for these two lung conditions, COPD and asthma, differ, both cause secondary complications (pulmonary hyperinflation, hyperventilation syndrome). These features lead to similar pathological changes that impair the diaphragm’s ability to elevate and expand the lower ribcage. 13 Consequently, during inspiration, the lower ribcage’s transverse diameter may decrease. 14

Over the past few decades, two research questions have emerged concerning how physiotherapy can enhance the mechanical efficiency of the thorax and the effectiveness of respiratory muscles during breathing in people with COPD. Researchers, from 1990 15 up to 2015, 16 have made several hypotheses and implemented physiotherapy interventions to find which procedure is more appropriate to improve the effectiveness of mechanical functioning of the thoracic cage in people with pulmonary diseases. Breathing retraining exercises (BRE) are a widely used, productive method, 17 19 simple, safe, accessible, with a high level of evidence-based efficacy. 20 22

Finally, although specific diaphragm MT techniques have not been documented yet, recent studies have reported evidence for their positive effect on pulmonary rehabilitation (PR). 23 In particular, the manual diaphragm release technique (MDRT) aims to directly stretch the muscle fibers of the diaphragm, as detailed in Rochas’ research. 16 The study showed an improvement in diaphragm’s mobility, maximum inspiratory pressure (MIP), and exercise capacity (EC) in people suffering from COPD. 16 As for asthma, there is no data for the efficacy of diaphragm MT methods, except for one pilot study. 24

Objective of the proposed trial

The primary objective of this study is to explore the impact of MDRT on the diaphragm’s function, particularly on the length-tension relationship and chest wall expansion (CWE) in people suffering from asthma. Secondary improvements are expected in the domain of dyspnea, asthma control and dysfunctional breathing. The MDRT in people with asthma may contribute to better disease management.

Methods

Study design

The present RCT will be a single centric, two arm parallel equivalence randomized clinical trial. This RCT followed the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) statement. 25 The completed SPIRIT checklist of the study is uploaded into an approved open repository (Reporting guidelines paragraph). The study’s flowchart is shown in Figure 1.

2f8e002e-b647-4ecb-9d49-0b230ff473bc_figure1.gif

Figure 1. Design of the trial.

Setting

The laboratory of Advanced Physiotherapy at the Physiotherapy Department of the University of West Attica (UNIWA) in Athens will be responsible for coordinating the trial. The recruitment of the patients will be conducted from the Pulmonology Department of the General Oncology Hospital of Kifissia “Agii Anargiri” (GOHK) in Athens (Greece). The hospital’s research committee approved the protocol (4479/09-03-22). Interventions and assessments will take place individually (home-based treatment) in Athens (Greece).

Recruitment procedures

The participants will be recruited from the GOHK. All participants will be out-patients with diagnosed stable asthma, referred by the director, pulmonologist, of the Pulmonary Department of the GOHK. The same pulmonologist will perform lung function testing on all participants (well-maintained and regularly calibrated equipment), will diagnose asthma and perform the measure of chest expansion. A radiologist will perform the ultrasonography (US) and a statistician will process the required analysis. Two separate physical therapists will implement the DMRT and BRE. All participants will read and sign the consent form. The declaration of consent refers to personal data privacy and participation protection. They will subsequently be informed about a) the objectives, methods, and details of the study, (b) that it will be the volunteers’ decision whether to take part or not, (c) they will always have the right to withdraw from the research even after signing, (d) they can also refuse to answer questions they will not wish or remain in the survey and (e) that the patient’s decision to participate will not affect the provision of our research services.

Randomization and blinding procedures

Following the initial assessment, eligible volunteers will be randomly assigned to two experimental groups if they meet the inclusion criteria by the secretariat of the Pulmonology Department of the GCHAA. The randomization will be carried out using sealed envelopes. Individuals will have their allocation concealed through the use of sealed envelopes that are sequentially numbered and opaque. 26 The envelopes will be opened only by the primary researcher, who is responsible for the research project and coordination of the study. The pulmonologist who will perform lung function testing on all participants (well-maintained and regularly calibrated equipment), diagnose asthma and perform the measure of chest expansion, the radiologist who will perform the ultrasonography (US), and the two separate physical therapists, who will implement the DMRT and BRE will be unaware of the group allocation.

Participants and eligibility

The pulmonologist of the trial will approach all eligible patients for recruitment into the study. They will be assessed through a set of questions to confirm eligibility. All patients will be requested to provide written informed consent (signed by the main researcher, the subject, and two witnesses) to participate in the study, including permission to publish results, with the understanding that they can withdraw at any time.

Participants’ characteristics

At least 24 adults will be recruited for the study.

Inclusion criteria: aged – 8-60 years, diagnosed with stable asthma 27 and correct use of the inhaler technique.

Exclusion criteria: Participation in other physical therapy methods, the presence of cardiopulmonary conditions, prior cardiothoracic or abdominal surgeries, recent chest wall or abdominal trauma, unstable hemodynamic parameters (systolic arterial pressure >140 mmHg and diastolic >90 mmHg), inability to comprehend verbal instructions required for outcome assessments, pregnancy, neurological ailments, and concurrent involvement in interventional programs.

Initial assessments

A pulmonologist of GOHK with years of experience diagnosing and treating asthma patients will examine the chest expansion, the pulmonary function, and diagnosis of asthma. The radiologist will perform the US assessment, and the secretariat of the GOHK will administer the questionnaires in a random order and collect all data.

Interventions

The pulmonologist and the main researcher of the protocol will organize two online sessions with all the participants after the randomization. In one session, participants will be informed by the pulmonologist about (a) general asthma information, (b) asthma triggers, (c) recognition of asthma symptoms, (d) medication and proper use of asthma medications (inhaler techniques), (e) smoking, and (f) asthma control (symptom control/future risk domains/long-term goals). 28 As for the last domain (asthma control), information will be provided regarding, (i) the dynamic changes of asthma, (ii) the recognition of these changes based on PEF values and symptoms, (iii) the importance of early detection of clinical signs of worsening and the immediate initiation of appropriate medication.

At the second online session the participants will be informed by the main researcher about (a) the breathing pattern, (b) the pathological pattern of breathing that is developing both in stable phase and in paroxysm, 29 (c) the role of physiotherapy and specifically about the BRE in PR, (d) the formation of a trusting relationship between a person living with asthma and a medical professional (e) the importance of self-efficacy in asthma self-management 30 33 and (f) the self-efficacy enhancement process.

Following the two online sessions, there will be a discussion between patients and health professionals (pulmonologist - main researcher) lasting approximately one hour, during which patients can share their objectives, values, apprehensions, support and commendations. The structure of the online session will be determined by a) the long-term objectives for asthma management 5 and b) the health belief model. 34 , 35 Regarding the treatment sessions, every participant will receive twelve sessions twice weekly for six weeks, lasting one hour per session. Individual sessions will be provided in patients’ homes under the same conditions (e.g., day, time of day, temperature, therapeutic bed, and patient’s position).

Physiotherapy intervention will be provided by two physical therapists, trained by the professor of chest physiotherapy and the professor of manual therapy respectively, at the Physiotherapy Department, UNIWA. Any departure from the administration of treatment sessions (such as missing more than one appointment) or any exacerbation of symptoms will lead to exclusion. Brief descriptions of the interventions planned for each group are provided below.

Intervention Group: This group will receive MDRT plus BRE. MDRT is intended to stretch and mobilize the diaphragmatic muscle fibers indirectly. MDRT will be applied as described by Rocha and his colleagues. 16

MDRT: Participants will be instructed to lie in a supine position with relaxed limbs. The therapist will be positioned at the patient’s head. Manual contact will be made using the hypothenar region and the last three fingers bilaterally, placed under the seventh to tenth rib costal cartilages. The therapist’s forearms will align towards the patient’s shoulders. During inhalation, the therapist will apply gentle pulling and lateral elevation of the ribs in the inspiratory phase at the points of contact. As the participant exhales, the therapist’s touch will deepen towards the inner costal margin while maintaining resistance. This connection will further deepen within the costal margin in subsequent respiratory cycles. The entire process will consist of two sets of 10 repetitions, separated by a 1-minute interval lasting 10 minutes. 36

BRE: BRE will be conducted for 30 minutes. The primary objective of these exercises is to mitigate hyperventilation, hypocapnia, and dysfunctional breathing—common symptoms in individuals with asthma. 37 The initial step involves identifying and inhibiting an abnormal upper thoracic respiratory pattern and re-education of diaphragmatic and slow nasal breathing. Additionally, brief respiratory pauses will be introduced after each exhalation. 38 Subsequently, BRE aims to integrate the new breathing pattern into daily life. This stage focuses on incorporating diaphragmatic and slow nasal breathing into various daily activities, encompassing physical activities (e.g., speaking, swimming, walking, gardening), social activities (e.g., playing with children or pets), and work-related activities (e.g., managing work stress). 39

The phases of BRE will consist of: i) identification of the abnormal breathing pattern, ii) diaphragmatic breathing, ii) nose breathing, iii) slow breathing with controlled breath-holding at the end of exhalation, iv) adaptation of the new breathing pattern in everyday life activities and various positions (supine, semi-sitting, sitting), and v) breathing control in speech.

Control Group: This group will receive only BRE, as mentioned in the intervention group.

Outcome measures

The evaluations will take place at three time - points: prior to treatment (week 0), post-treatment (week 6), and three months subsequent (week 12). The primary outcomes will entail the measurement of diaphragm excursion using ultrasound 40 and chest expansion (CE) using a tape measure. 41 Secondary outcomes will also be employed: maximal inspiratory and expiratory pressures (MIP/MEP), 42 , 43 dysfunctional breathing (Nijmegen questionnaire – - NQ), 44 asthma Control (ACT), 45 , 46 quality of life (SF-12v2), 47 and dyspnea (Borg scale). 48 Table 1 illustrates the SPIRIT schematic protocol of the study along with the schedule of assessments.

Table 1. Standard protocol items: recommendations for interventional trials of this study.

TIME POINTEnrollment (-T1)Allocation (T0)Pre-intervention (T1)InterventionPost-Intervention
(T2)(T3)
ENROLLMENT:
Eligibility screenX
Informed consentX
Demographic informationX
AllocationX
Intervention
MDRT + BRE 2f8e002e-b647-4ecb-9d49-0b230ff473bc_Gra1.gif
BRE 2f8e002e-b647-4ecb-9d49-0b230ff473bc_Gra2.gif
ASSESMENTS 2f8e002e-b647-4ecb-9d49-0b230ff473bc_Gra3.gif
Neurological and cardiovascular assessmentsX
Primary outcomes: USXXX
CEXXX
Secondary outcomes: MIP/MEPXXX
NQXXX
ACTXXX
Borg scaleXXX
SF-12v2XXX

Primary outcome measures

Diaphragmatic excursion assessment with ultrasonography: Numerous studies have confirmed the effectiveness of the US to evaluate diaphragmatic function. Since 1970, 49 the US has been utilized to assess the diaphragm’s mobility. Modern medicine accepts its use as a completely safe method. The diagnostic US has 93% sensitivity and 100% specificity. 15 The examiners are not exposed to any radiation, and there is no need for special preparation, allowing for as many safe applications as required. The US offers the option of a dynamic inspection of the affected area in real time. The diaphragmatic excursion is measured in cm/mm.

Chest wall expansion (CWE): In clinical and research practice, the inch tape measure is an alternative method for assessing chest expansion. 50 By placing the tape measure at the level of the axilla (about the level of the sternal angle of Louis), the level of the xiphoid process, or between the xiphoid process and the umbilicus, the therapist identifies the upper, middle, and lower chest wall expansion, respectively. The therapist should repeat the measurement at least three times for each level for higher fidelity. 41 A tape measure (in centimeters) will assess the variance between values recorded during deep inhalation and exhalation, with greater values signifying improved results. 41 Norms have been developed according to age and sex. 51

Secondary outcome measures

Nijmegen Questionnaire (NQ): The Nijmegen Questionnaire is a reliable and valid tool for assessing dysfunctional breathing in clinical practice and research. It is designed to identify the Hyperventilation Syndrome (HS). A score greater than 23 indicates the presence of HS in the general population. The NQ has shown 91% sensitivity and 95% specificity. 52 In previous research, NQ scores of 20, 22 and 23 have been used as cut-off scores to detect HS in subjects with and without asthma. 53 55 The NQ questionnaire has been validated in Greek adults with asthma, providing evidence of validity and reliability of measurements with a cut-off score of >17. 56

Asthma control test (ACT): The ACT questionnaire is a valid and reliable clinical and research tool. 57 Its quick completion time is one of its key features. It has five items, all about the most recent four weeks. 57 , 58 The ACT evaluates the frequency of wheezing and other general asthma symptoms and the need for emergency control self-assessment. The score ranges from 5 (poor control of asthma) to 25 (good control of asthma). An ACT score >19 indicates controlled asthma. The ACT has been validated in the Greek population with asthma and has shown high indices of internal consistency (0.72) and test–retest reliability (IR = 0.85). 49

Sf-12v2 questionnaire: A simplified version of the SF-36 includes medications, and how well asthma affects daily functioning and overall asthma. The SF-12v2 is a practical, reliable, and valid way to assess physical and mental health. With one or two questions per domain, it assesses the exact eight health dimensions as the SF-36v2, which includes Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional, and Mental Health. The SF-12 is a valid alternative to the lengthy SF-36 for the self-assessment of quality of life by assessing the health status of healthy and patient population groups. 59 Higher ratings indicate better physical and mental wellbeing, ranging from 0 to 100. 60 It has been suggested that a cut-off of 50 or less can be used to identify a physical condition, while a score of 42 or less may signify clinical depression. 60 The Sf-12v2 has been weighted in the Greek general population. 61

Borg scale: The Borg dyspnea scale is a simple, non-proprietary scoring system. It is extensively used in clinical and research practice to evaluate symptoms of shortness of breath and provides valuable data. 62 , 63 It begins with 0 (no dyspnea), and goes up to 10 (extreme dyspnea). As a result, healthcare professionals must give patients enough time to learn and ensure they comprehend it before using it. 64

Anticipated dates of trial commencement and completion

The study started in January 2023 and is scheduled to be completed in January 2024.

Sample size calculation

Sample size estimation was conducted using G*Power, version 3.1 software. For a study design involving two separate groups and three repeated measurements (pre-treatment, post-treatment, and one follow-up) to attain a statistical power of 0.80 for detecting an effect size (d) of 1.36 in the interaction effect (22), with a significance level of 5% (0.05), a minimum of 6 participants per group was determined as necessary. Accounting for a potential dropout rate of 10% and based on the calculated sample size, it was anticipated that approximately 12 individuals per group would need to be initially recruited. 65

Data collection methods

Data regarding the outcomes pre and post-intervention will be meticulously collected from the main researcher. The collected information will undergo a thorough examination to analyze the outcomes. Throughout the study, the professor of chest physiotherapy (supervisor) will closely oversee the main researcher administering the study’s data. To ensure the patient adheres to the study, timely messages will be sent to their mobile phones, providing information and reminders regarding upcoming sessions. A 10% drop-out rate has been considered in the sample size calculation, thus minimizing potential interference with the study results.

Data management

Evaluation data will be sourced from a predefined spreadsheet containing baseline characteristics. A secure database will be employed to store all research-related data securely. Paper copies of evaluation forms signed informed consent forms, and other non-electronic documents will be securely stored in the study environment. A comprehensive backup of the data entries will be generated once a month until the conclusion of the trial.

Upon completion of the study, the Excel spreadsheet will be published and forwarded to the statistician for the necessary analysis. A checklist will help prevent data loss from inefficient staff procedures. Given the extensive follow-up assessment for this experiment, participant retention and completion of follow-up assessments will be notably high. After six weeks from the end of interventions, the participants will be invited to a follow-up examination (12 weeks from the beginning of the trial).

Statistical analysis

The IBM SPSS software, specifically version 28, will be utilized for all data processing. The distribution of the data will be displayed using descriptive statistics. For each dependent variable independently (US, CWE, ACT, NQ, SF-12v2 and Borg scale), 2×3 ANOVA repeated measures, with Bonferroni adjustment will be used to examine the interaction between intervention (experimental and control group) and time (0, 6, and 12 weeks). The level of statistical significance was chosen at 0.05.

Monitoring

Data monitoring

A data monitoring committee of members from the UNIWA Physiotherapy Department will periodically review the accumulating data, determining if the trial should be modified or discontinued.

Harms

A clinical staff is going to supervise the entire procedure. Any adverse events will be immediately reported throughout the trial to the Physiotherapy Department of the UNIWA committee.

Auditing

An evaluation of the experiment will be performed each month. Every deviation from the protocol will be recorded and addressed.

Ethics and dissemination

Research ethics approval

The Ethics Committee of the UNIWA in Greece approved this study under protocol 90853/04-10-2022. The study follows the Helsinki Declaration’s “Ethical Principles of Medical Research Involving Human Subjects.” Protocol modifications will be disclosed to the Ethics Committee as soon as possible. The trial has been proactively registered in the ClinicalTrials.gov database with the identification number NCT05709054.

Protocol amendments

The study has already been modified and accepted in accordance with the Ethics Committee of the UNIWA in Greece suggestions. As a result, further modifications could not be made.

Consent

Study participants will receive a translated version of the study protocol. Prior to participation, all individuals involved in the study will be fully informed, and written consent will be obtained from each participant.

Confidentiality

The main researcher will collect personal data during the trial. A confidentiality statement on the permission form will be signed by the main researcher, the subject, and two witnesses. Whenever necessary to disclose information for the study, consent from the patients will always be obtained with utmost assurance of confidentiality.

Access to data

The main researcher and the statistician will have access to the final trial datasheet.

Ancillary and post-trial care

The entire procedure will be conducted under the oversight of clinicians and the physiotherapy department of the UNIWA committee. After the trial sessions, the participants will be under supervision for about four weeks so that they can take care if there is any harm.

Discussion

Although several studies assessing the efficacy of MT in obstructive lung diseases have been conducted, drawing definitive conclusions is challenging due to their conflicting results. 37 A review of the existing literature has outlined a model of how MT delays the onset of fatigue in respiratory muscles. 66 It reduces respiratory muscle effort by allowing them to function closer to their optimal length. 38 Remarkably, as of now, no RCT has explored the impact of manual therapy, specifically focusing on the zone of apposition (ZOA) of the diaphragm in individuals with asthma.

This is the first RCT endeavoring to investigate the influence of the manual diaphragm release technique on DE, CE, MIP, MEP, asthma control, dyspnea, and overall quality of life in individuals diagnosed with asthma. The study’s strength will be the high internal validity since this protocol is planned according to accepted methodology regarding randomization, concealed allocation, blinding of examiners, and appropriate sample size calculation. What sets this study apart is its original investigation into the mechanism of the MDRT on the ZOA of the diaphragm in individuals living with asthma.

Finally, several significant constraints must be considered. The study sample is drawn exclusively from a single hospital, potentially limiting the generalizability of the findings. Additionally, the extended experimental period and the substantial number of sessions may lead to participant dropouts.

Study status

The study started in January 2023.

Study dissemination

This work will be presented in International Conference Proceedings and published in an indexed journal.

Conclusions

This RCT will be innovative as it will, for the first time, provide evidence of the effect of the MDRT on diaphragm function in people with asthma. MT is a low-cost alternative and supplementary therapy to standard treatment procedures that might improve the biomechanics of respiration in pulmonary rehabilitation.

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 18 Oct 2023
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Tsimouris D, Grammatopoulou E, Papandreou M et al. The effect of manual therapy on diaphragm function in adults with asthma: Protocol for a randomized controlled trial [version 1; peer review: 2 approved with reservations]. F1000Research 2023, 12:1361 (https://doi.org/10.12688/f1000research.141455.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 18 Oct 2023
Views
30
Cite
Reviewer Report 20 Feb 2024
Ragab K. Elnaggar, Department of Physical Therapy and Health Rehabilitation, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al Kharj, Riyadh Province, Saudi Arabia;  Department of Physical Therapy for Pediatrics, Faculty of Physical Therapy, Cairo University, Giza, Egypt 
Approved with Reservations
VIEWS 30
This protocol for a prospective, randomized clinical trial will assess the effect of manual diaphragm release technique (MDRT) on diaphragm function in individuals with asthma. While, based on a brief search of the database, previous evidence on the effect of ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Elnaggar RK. Reviewer Report For: The effect of manual therapy on diaphragm function in adults with asthma: Protocol for a randomized controlled trial [version 1; peer review: 2 approved with reservations]. F1000Research 2023, 12:1361 (https://doi.org/10.5256/f1000research.154901.r223569)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 13 Apr 2024
    DIMITRIOS TSIMOURIS, Physiotherapy Department, ,, Egaleo, 12243, Greece
    13 Apr 2024
    Author Response
    Dear Ragab Elnaggar,

    Thank you for your thorough review and insightful feedback on our study protocol. Your contributions have significantly enhanced the quality of our work. We will meticulously ... Continue reading
  • Author Response 13 Apr 2024
    DIMITRIOS TSIMOURIS, Physiotherapy Department, ,, Egaleo, 12243, Greece
    13 Apr 2024
    Author Response
    Dear Prof. Ragab Elnaggar,

    We would like to thank you for reviewing our manuscript and giving us the opportunity to revise it. We appreciate the time and effort you ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 13 Apr 2024
    DIMITRIOS TSIMOURIS, Physiotherapy Department, ,, Egaleo, 12243, Greece
    13 Apr 2024
    Author Response
    Dear Ragab Elnaggar,

    Thank you for your thorough review and insightful feedback on our study protocol. Your contributions have significantly enhanced the quality of our work. We will meticulously ... Continue reading
  • Author Response 13 Apr 2024
    DIMITRIOS TSIMOURIS, Physiotherapy Department, ,, Egaleo, 12243, Greece
    13 Apr 2024
    Author Response
    Dear Prof. Ragab Elnaggar,

    We would like to thank you for reviewing our manuscript and giving us the opportunity to revise it. We appreciate the time and effort you ... Continue reading
Views
35
Cite
Reviewer Report 25 Oct 2023
Luis Vicente Franco Oliveira, Human Movement and Rehabilitation Post Graduation Program, Evangelical University of Goiás, Anápolis, Goiás, Brazil 
Approved with Reservations
VIEWS 35
This RCT will be innovative as it will, for the first time, provide evidence of the effect of the manual diaphragm release technique on diaphragm function in people with asthma. Manual Therapy is a low-cost alternative and supplementary therapy to ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Oliveira LVF. Reviewer Report For: The effect of manual therapy on diaphragm function in adults with asthma: Protocol for a randomized controlled trial [version 1; peer review: 2 approved with reservations]. F1000Research 2023, 12:1361 (https://doi.org/10.5256/f1000research.154901.r216768)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 28 Nov 2023
    DIMITRIOS TSIMOURIS, Physiotherapy Department, ,, Egaleo, 12243, Greece
    28 Nov 2023
    Author Response
    Dear Luis Vicente Franco Oliveira,

    I extend my sincere thanks for your meticulous evaluation of our study protocol and for providing valuable feedback that helped us improve our work's ... Continue reading
  • Author Response 13 Apr 2024
    DIMITRIOS TSIMOURIS, Physiotherapy Department, ,, Egaleo, 12243, Greece
    13 Apr 2024
    Author Response
    Dear Prof. Luis Vicente Franco Oliveira,

    We would like to thank you for allowing us to revise the manuscript. We appreciate the time and effort you put into this ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 28 Nov 2023
    DIMITRIOS TSIMOURIS, Physiotherapy Department, ,, Egaleo, 12243, Greece
    28 Nov 2023
    Author Response
    Dear Luis Vicente Franco Oliveira,

    I extend my sincere thanks for your meticulous evaluation of our study protocol and for providing valuable feedback that helped us improve our work's ... Continue reading
  • Author Response 13 Apr 2024
    DIMITRIOS TSIMOURIS, Physiotherapy Department, ,, Egaleo, 12243, Greece
    13 Apr 2024
    Author Response
    Dear Prof. Luis Vicente Franco Oliveira,

    We would like to thank you for allowing us to revise the manuscript. We appreciate the time and effort you put into this ... Continue reading

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 18 Oct 2023
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.